Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands |
3 Months Ended |
Apr. 30, 2023 |
Apr. 30, 2022 |
| Cash flows from operating activities: |
|
|
| Net income |
$ 3,634
|
$ 574
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
| Depreciation and amortization |
17,503
|
18,048
|
| Stock-based compensation, excluding cash-settled awards |
14,814
|
18,364
|
| Losses on early retirements of debt |
237
|
0
|
| Other, net |
45
|
2,163
|
| Changes in operating assets and liabilities, net of effects of business combinations and divestitures: |
|
|
| Accounts receivable |
31,124
|
41,766
|
| Contract assets |
1,923
|
4,024
|
| Inventories |
(937)
|
68
|
| Prepaid expenses and other assets |
21,278
|
(8,686)
|
| Accounts payable and accrued expenses |
(6,821)
|
(5,694)
|
| Contract liabilities |
(19,245)
|
(9,645)
|
| Deferred income taxes |
90
|
(1,074)
|
| Other, net |
(3,638)
|
(5,982)
|
| Net cash provided by operating activities |
60,007
|
53,926
|
| Cash flows from investing activities: |
|
|
| Purchases of property and equipment |
(4,923)
|
(5,224)
|
| Maturities and sales of investments |
232
|
250
|
| Purchases of investments |
(3,180)
|
(250)
|
| Cash paid for capitalized software development costs |
(1,868)
|
(2,003)
|
| Change in restricted bank time deposits, and other investing activities, net |
(1,019)
|
20
|
| Net cash used in investing activities |
(10,758)
|
(7,207)
|
| Cash flows from financing activities: |
|
|
| Proceeds from borrowings |
100,000
|
0
|
| Repayments of borrowings and other financing obligations |
(100,530)
|
(775)
|
| Payments of debt-related costs |
(9)
|
(93)
|
| Purchases of treasury stock and common stock for retirement |
(60,294)
|
(105,213)
|
| Preferred stock dividend payments |
(10,400)
|
(10,400)
|
| Distributions paid to noncontrolling interest |
(245)
|
0
|
| Payments of contingent consideration for business combinations (financing portion), and other financing activities |
(8)
|
(1,549)
|
| Net cash used in financing activities |
(71,486)
|
(118,030)
|
| Foreign currency effects on cash, cash equivalents, restricted cash, and restricted cash equivalents |
859
|
(2,431)
|
| Net decrease in cash, cash equivalents, restricted cash, and restricted cash equivalents |
(21,378)
|
(73,742)
|
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period |
282,161
|
358,868
|
| Cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period |
$ 260,783
|
$ 285,126
|